Centre Paul Strauss

The medical center is at the forefront of oncology research, particularly in the treatment of head and neck cancers. The institution is pioneering studies that explore the combination of durvalumab with radiotherapy to enhance treatment efficacy and safety.

• Head and Neck Cancer Treatment
• Immunotherapy and Radiotherapy Synergy
• Squamous Cell Carcinoma Management

By focusing on regional control of the disease, the center aims to improve outcomes for patients with squamous cell carcinoma of the head and neck, offering innovative approaches that minimize unnecessary exposure to radiation.